LivaNova PLC (LIVN)

↓ Download CSV

CIK 0001639691 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated X0
  • Fiscal year ends Dec 31

In fiscal 2025, LivaNova PLC reported revenue of $1.39B, up 10.7% from the prior year. The company ran a net loss, with a net margin of -17.5% and a gross margin of 67.7%. It held $2.61B in total assets against $1.41B in total liabilities.

Key ratios (FY2025)

67.7%
Gross margin
14.4%
Operating margin
-17.5%
Net margin
-20.2%
Return on equity
+10.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.39B$1.25B$1.15B$1.02B$1.04B$934.24M$1.08B$1.11B$1.01B$964.86M
Cost of Revenue$448.18M$399.95M$397.73M$314.58M$329.37M$339.48M$360.37M$361.32M$353.19M$367.85M
Gross Profit$939.87M$853.48M$755.82M$707.23M$705.99M$594.76M$723.80M$651.62M$559.51M
Operating Income$199.39M$129.05M-$68.50M-$76.75M-$784.0K-$273.90M-$171.55M-$248.07M$96.49M$33.45M
Net Income-$242.47M$63.23M$17.55M-$86.25M-$135.82M-$348.82M-$157.64M-$189.40M-$25.09M-$62.79M
EPS (Diluted)$-4.45$1.16$0.32$-1.61$-2.68$-7.18$-3.26$-3.91$-0.52$-1.28
Total Assets$2.61B$2.51B$2.43B$2.29B$2.20B$2.40B$2.41B$2.55B$2.50B$2.34B
Total Liabilities$1.41B$1.19B$1.15B$1.09B$906.31M$1.29B$1.03B$1.05B$688.58M$635.72M
Shareholders' Equity$1.20B$1.32B$1.28B$1.21B$1.29B$1.11B$1.38B$1.50B$1.82B$1.71B
Cash & Equivalents$635.55M$428.86M$266.50M$214.17M$207.99M$252.83M$61.14M$47.20M$93.61M$39.79M
Operating Cash Flow$254.34M$183.04M$74.91M$69.92M$102.54M-$79.42M-$91.14M$120.49M$91.34M$90.15M
Capital Expenditures$81.05M$47.11M$34.98M$26.52M$25.48M$35.02M$24.69M$37.19M$32.93M$38.36M
Shares Outstanding54.65M54.35M53.92M53.56M53.26M48.66M48.44M48.21M48.29M48.03B